Trial Outcomes & Findings for Longitudinal Evaluation of Silicone Hydrogel (LASH) Study (NCT NCT00727402)
NCT ID: NCT00727402
Last Updated: 2012-02-15
Results Overview
Unadjusted cumulative incidence of corneal inflammatory events (CIE)using survival analysis methods. CIE are corneal infiltrates found in an otherwise clear cornea.
Recruitment status
COMPLETED
Target enrollment
205 participants
Primary outcome timeframe
annual
Results posted on
2012-02-15
Participant Flow
Participant milestones
| Measure |
Observational
healthy patients fit into lotrafilcon A contact lenses for continuous wear
|
|---|---|
|
Overall Study
STARTED
|
205
|
|
Overall Study
COMPLETED
|
89
|
|
Overall Study
NOT COMPLETED
|
116
|
Reasons for withdrawal
| Measure |
Observational
healthy patients fit into lotrafilcon A contact lenses for continuous wear
|
|---|---|
|
Overall Study
Physician Decision
|
116
|
Baseline Characteristics
Longitudinal Evaluation of Silicone Hydrogel (LASH) Study
Baseline characteristics by cohort
| Measure |
Observational
n=205 Participants
healthy patients fit into lotrafilcon A contact lenses for continuous wear
|
|---|---|
|
Age Continuous
|
32.8 years
STANDARD_DEVIATION 5 • n=93 Participants
|
|
Age, Customized
<=21 years
|
26 participants
n=93 Participants
|
|
Age, Customized
Between 21 and 50 years
|
163 participants
n=93 Participants
|
|
Age, Customized
>50 years
|
16 participants
n=93 Participants
|
|
Sex: Female, Male
Female
|
157 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
48 Participants
n=93 Participants
|
|
Region of Enrollment
United States
|
205 participants
n=93 Participants
|
PRIMARY outcome
Timeframe: annualUnadjusted cumulative incidence of corneal inflammatory events (CIE)using survival analysis methods. CIE are corneal infiltrates found in an otherwise clear cornea.
Outcome measures
| Measure |
Observational
n=410 eyes
healthy patients fit into lotrafilcon A contact lenses for continuous wear
|
|---|---|
|
Cumulative Incidence of Corneal Inflammatory Events
|
26.7 annual incidence per 100 subjects
Interval 20.1 to 35.0
|
Adverse Events
Observational
Serious events: 0 serious events
Other events: 58 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Observational
n=205 participants at risk
healthy patients fit into lotrafilcon A contact lenses for continuous wear
|
|---|---|
|
Eye disorders
corneal inflammatory event
|
18.5%
38/205 • Number of events 44
|
|
Eye disorders
Other non-Corneal Inflammatory Event
|
9.8%
20/205
|
Additional Information
Loretta Szczotka-Flynn OD, PhD
Case Western Reserve University Dept Ophthalmology & Visual Sciences
Phone: 216-844-3609
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place